Companies /Healthcare
Waystar Holding Corp. Common Stock
NASDAQ: WAY Health Information Services
$26.68
▲ $0.20 (+0.76%) today
Markets closed · 11:34pm ET

Waystar (WAY) Q2 2025 Earnings

Reported Jul 30, 2025, 4:04pm ET · SEC source
$0.36
Beat +6.19%
EPS · est. $0.34
$270.7M
Beat +4.93%
Revenue · est. $257.9M
−1.1%
Trailing market
WAY vs S&P since report
2 quarters
Consecutive EPS beats

How Did WAY Stock React to Q2 2025 Earnings?

% change · around the report
−8%−4%0Jul 30Jul 31report 4:04pm ETearnings−0.7%−1.4%
−8%−4%0Jul 30Jul 31earnings−0.7%−1.4%
WAY −1.4%S&P 500 −0.7%
−8%−4%0Jul 30Jul 31report 4:04pm ETearnings−0.9%−1.4%
−8%−4%0Jul 30Jul 31earnings−0.9%−1.4%
WAY −1.4%NASDAQ −0.9%
−8%−4%0+4%Jul 29Aug 7report 4:04pm ETearnings−0.7%−8.8%
−8%−4%0+4%Jul 29Aug 7earnings−0.7%−8.8%
WAY −8.8%S&P 500 −0.7%
−8%−4%0+4%Jul 29Aug 7report 4:04pm ETearnings−0.4%−8.8%
−8%−4%0+4%Jul 29Aug 7earnings−0.4%−8.8%
WAY −8.8%NASDAQ −0.4%
+3.76%
Day of report
−3.76%
Next session
−8.30%
One week
+0.16%
30 days

S&P 500 over the same 30 days: +1.30%.

Did WAY Beat Earnings? Q2 2025 Results

Yes. Waystar reported Q2 2025 earnings of $0.36 a share on Jul 30, 2025, beating the $0.34 consensus estimate by 6.2%. Revenue was $270.7M against a $257.9M estimate.

Waystar posted a clean beat across the board in the second quarter, with non-GAAP EPS of $0.36 clearing the $0.34 consensus by 6.19% and revenue of $270.65 million topping estimates by 4.93% on 15.4% year-over-year growth. The healthcare payments software company swung to GAAP net income of $32.18 million from a loss of $27.68 million a year ago, a shift driven largely by sharply lower stock-based compensation and meaningful reductions in interest expense following debt paydown that brought net leverage to 2.2x from 3.7x a year earlier. Adjusted EBITDA margin expanded to 41.6% from 40.0%, reflecting the operating leverage the company has been building as subscription revenue grew 17% and volume-based revenue rose 14%. A net revenue retention rate of 115% and a 14% increase in clients generating over $100,000 annually underscored the stickiness of the platform. Management raised full-year 2025 revenue guidance to between $1.03 billion and $1.04 billion, and the pending $1.25 billion acquisition of clinical AI firm Iodine Software signals an intent to push deeper into AI-powered healthcare workflows.

Key Takeaways
  • 15% year-over-year revenue growth driven by AI-powered innovations and trusted client relationships
  • Net revenue retention rate of 115%
  • 1,268 clients contributing over $100,000 in LTM revenue, up 14% year-over-year
  • Subscription revenue growth of 17% and volume-based revenue growth of 14%
  • Adjusted EBITDA margin expansion to 41.6% from 40.0% year-over-year
  • Significant reduction in interest expense following debt reduction

“Waystar recorded strong Q2 results, including 15% revenue growth, driven by AI-powered innovations, trusted client relationships, and compelling and real ROI for healthcare providers.”

Waystar CEO, on the earnings call

What Was Waystar's Outlook in Q2 2025?

For full fiscal year 2025 (excluding the pending Iodine Software acquisition), Waystar raised guidance: total revenue is expected between $1.030 billion and $1.042 billion; adjusted EBITDA between $418 million and $426 million; non-GAAP net income between $251 million and $257 million; and diluted non-GAAP net income per share between $1.36 and $1.40.

WAY YoY Financials

Q2 2025 vs Q2 2024 · SEC filings Q2 2024 Q2 2025
$0$80.0M$160.0M$240.0M$234.5M$270.7MRevenue$154.1M$183.6MGross Profit$8.2M$64.8MOperating Income$10.2M$32.2MNet Income
$0$80.0M$160.0M$240.0MRevenueGross ProfitOperating IncomeNet Income
WAY income statement, Q2 2025 versus Q2 2024
Metric Q2 2025 Q2 2024 Year over year
Revenue $270.7M $234.5M +15.4%
Gross Profit $183.6M $154.1M +19.2%
Operating Income $64.8M $8.2M +686.5%
Net Income $32.2M $10.2M +216.3%

WAY Revenue by Segment

Subscription Revenue$131.1M+17.0%
Volume-Based Revenue$138.3M+14.0%

Figures from SEC filings and company reports. Not investment advice.